Oct 01, 2021 · 2022 ICD-10-CM Diagnosis Code Z85.05 Personal history of malignant neoplasm of liver 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code POA Exempt Z85.05 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z85.05 became effective on October 1, 2021.
Search Results. 500 results found. Showing 1-25: ICD-10-CM Diagnosis Code Z85.05 [convert to ICD-9-CM] Personal history of malignant neoplasm of liver. History of cancer metastatic (spread) to liver; History of cancer metastatic to liver; History of cancer of the liver; History of hepatoblastoma; History of hepatoblastoma (tumor of the liver); History of hepatocellular …
Code Z85.05 ICD-10-CM Code Z85.05 Personal history of malignant neoplasm of liver BILLABLE POA Exempt | ICD-10 from 2011 - 2016 Z85.05 is a billable ICD code used to specify a diagnosis of personal history of malignant neoplasm of liver. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
Oct 01, 2021 · 2022 ICD-10-CM Diagnosis Code Z85.9 Personal history of malignant neoplasm, unspecified 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code POA Exempt Z85.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z85.9 became effective on October 1, 2021.
ICD-10-AM code | n with code |
---|---|
Cirrhosis | |
K70.3 Alcoholic cirrhosis of liver | 193 |
K74.4 Secondary biliary cirrhosis* | 12 |
K74.5 Biliary cirrhosis, unspecified | 6 |
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
There are also codes Z85.6, Personal history of leukemia, and Z85.79, Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues. If the documentation is unclear as to whether the leukemia has achieved remission, the provider should be queried.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
When a patient is admitted because of a primary neoplasm with metastasis and treatment is directed toward the secondary site only , the secondary neoplasm is designated as the principal diagnosis even though the primary malignancy is still present .
Code C80.0, Disseminated malignant neoplasm, unspecified, is for use only in those cases where the patient has advanced metastatic disease and no known primary or secondary sites are specified. It should not be used in place of assigning codes for the primary site and all known secondary sites.
Code C80.1, Malignant ( primary) neoplasm, unspecified, equates to Cancer, unspecified. This code should only be used when no determination can be made as to the primary site of a malignancy. This code should rarely be used in the inpatient setting.
When a primary malignancy has been excised but further treatment, such as an additional surgery for the malignancy, radiation therapy or chemotherapy is directed to that site, the primary malignancy code should be used until treatment is completed.